Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions.
about
Segmentation of epidermal tissue with histopathological damage in images of haematoxylin and eosin stained human skinInterventions for melanoma in situ, including lentigo malignaInterventions for melanoma in situ, including lentigo malignaSimulants of Malignant MelanomaThe framework of pathology: good laboratory practice by quantitative and molecular methods.Risk management in dermatology: an analysis of data available from several British-based reporting systems.Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility studyLow rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi.Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspectsDiscordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting.A multi-marker assay to distinguish malignant melanomas from benign nevi.The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.Dysplastic nevus (atypical nevus).Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.Molecular markers in melanoma.Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.Pathology review significantly affects diagnosis and treatment of melanoma patients: an analysis of 5011 patients treated at a melanoma treatment center.Micro-structural tissue analysis for automatic histopathological image annotation.Molecular dermatopathology in malignant melanoma.Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy.Impact of digital dermoscopy analysis on the decision to follow up or to excise a pigmented skin lesion: a multicentre study.Precursors to melanoma and their mimics: nevi of special sites.Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.A study assessing the feasibility and diagnostic accuracy of real-time teledermatopathology.Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.p16 Expression Is Lost in Severely Atypical Cellular Blue Nevi and Melanoma Compared to Conventional, Mildly, and Moderately Atypical Cellular Blue Nevi.Dysplastic (or Atypical) Nevi Showing Moderate or Severe Atypia With Clear Margins on the Shave Removal Specimens Are Most Likely Completely Excised.Raman Spectroscopy for Clinical OncologyHistologic review of melanomas by pathologists trained in melanocytic lesions may change therapeutic approach in up to 41.9% of cases
P2860
Q21261522-5428A76E-C10C-4137-8341-4369FC9883EEQ24187170-C11FC8CF-A9C3-4DDB-A1EF-7CF79A3D0898Q24202030-B8D6A67B-A383-4143-8400-EF9AB4C361B7Q26771419-086A849D-CF01-4921-B550-589F9CA45E41Q30862047-98C1AFEE-EB03-41D8-9FED-4F2C5AC78C72Q33766477-B8FE96DB-7303-4877-872B-1066593A48DDQ33838249-48441C21-D758-4D7A-AFBD-280A73CABC41Q33917739-DA6237CC-148A-4A59-B27D-CD4F0F60A0F3Q35324807-84F4C346-ADF5-4E4B-9983-9D621DC0BD20Q36634810-5FAD4C59-5AAB-4E16-BD03-EA50466547BCQ36752192-734B1E8D-061F-4B14-9267-CAD0FF6AC9A4Q36762792-8B879E3E-B618-495B-B905-30AEE51703EAQ37107493-CB611E3E-8F05-4ACD-A398-92FB81E24D8AQ37144478-E42C5AB0-BFB8-46B4-BD74-483FDF0B8224Q37712566-72CEDC86-101E-42F8-8C01-E8F46070DB89Q37838754-F869D451-B408-4EB7-BFA1-A8ADD310DBB7Q37886997-D7100B6E-F221-43D8-B254-A962C958717CQ38118361-CDE002D4-D3B3-48E8-8BE1-E8BE08F542F0Q38121417-686D5AF6-B426-4436-B3CD-82686BA272F6Q38205705-5BABAAA4-D2DA-45F9-82E4-E23928DC37EDQ38482827-21B18FA0-E38C-43DD-AEF9-ADE43AA497F8Q38789271-54365119-1C69-4F07-8495-33B43F5161F2Q38818516-B56A549E-1395-4003-924F-F1D9DAC60EA2Q39977003-84F23D57-DD17-4369-A3EC-06AABE0DDFBAQ40354356-54540A58-3FD2-4756-94C1-FCB4AF51CF5CQ40630464-D3D964B8-CC33-4468-9259-E5E2F440D902Q41010111-68A0E3D1-D7B4-4825-9C1C-2AA852EA9BEBQ41066052-22909F3C-40D8-498E-B4A7-3C714E9D9C6BQ41812859-B44EA3C2-6CC8-4038-B92C-6953A4F67CF0Q51629623-8F76FFC2-B13F-4BC1-A2EC-7387D45E9868Q58655044-677B0D75-8FA8-4305-8DD5-0438A399316DQ58777595-D38239D3-D4C0-4009-8078-107237F81984
P2860
Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inter-observer variation in th ...... icious pigmented skin lesions.
@en
Inter-observer variation in th ...... icious pigmented skin lesions.
@nl
type
label
Inter-observer variation in th ...... icious pigmented skin lesions.
@en
Inter-observer variation in th ...... icious pigmented skin lesions.
@nl
prefLabel
Inter-observer variation in th ...... icious pigmented skin lesions.
@en
Inter-observer variation in th ...... icious pigmented skin lesions.
@nl
P2093
P2860
P356
P1476
Inter-observer variation in th ...... icious pigmented skin lesions.
@en
P2093
Dirk Ruiter
Eckhart Haneke
Edouard Grosshans
Evelien Verhaeghe
Gérald Piérard
Jean-Marie Naeyaert
Lieve Brochez
P2860
P304
P356
10.1002/PATH.1061
P577
2002-04-01T00:00:00Z